Stay updated on Tislelizumab After Liver-Directed Therapy Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab After Liver-Directed Therapy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record now presents details for a recruiting Phase 2 study of tislelizumab after liver-directed therapy for hepatocellular carcinoma, including its eligibility criteria, treatment plan, outcomes, locations, and contacts.
    Difference
    54%
    Check dated 2026-11-07T12:09:49.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:45:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition-related updates about terminology for artificial intelligence. The page continues to show a 403 error instead of the study record.
    Difference
    1%
    Check dated 2026-10-24T12:24:57.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T14:11:44.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T15:18:07.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The 403 Forbidden page content and the Home link were removed from the page chrome. This represents a cleanup of non-core UI elements without modifying study details.
    Difference
    0.5%
    Check dated 2026-09-26T17:05:12.000Z thumbnail image

Stay in the know with updates to Tislelizumab After Liver-Directed Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.